Article
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Cancer genetics and cytogenetics - 1 Mar 2007
Bae Nack Cheon, Chae Myung Hwa, Lee Myung Hoon, Kim Kyung Mee, Lee Eung Bae, Kim Chang Ho, Park Tae-In, Han Sung Beom, Jheon Sanghoon, Jung Tae Hoon, Park Jae Yong
Abstract excerpt
The epidermal growth factor receptor (EGFR), and its family members play an important role in the development and progression of lung cancers. It has been reported that somatic mutations in the tyrosine kinase domain of the EGFR or ERBB2 genes occur in a subset of patients with lung cancer. We searched for mutations of the EGFR, ERBB2, and KRAS genes in surgically resected non-small cell lung cancers (NSCLCs) to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
